Acute myeloid leukemia (AML), also known as acute myelogenous leukemia, acute myeloblastic leukemia, acute granulocytic leukemia or acute nonlymphocytic leukemia, is a fast-growing form of cancer of the blood and bone marrow. Incidence is the total number of new cases of cancer. Mortality is the number of deaths due to cancer. The most recent incidence statistics for acute myelogenous leukemia are from 2010: 1,215 Canadians were diagnosed with acute myelogenous leukemia.
Symptom: Acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL) progress much faster and symptoms may worsen more quickly than with the chronic leukemias (CML and CLL).Some leukemia symptoms, like night sweats, fever, fatigue and achiness, often resemble flu-like symptoms. If you have the flu, symptoms will likely subside as you get better. Make an appointment to see your doctor if the symptoms persist longer than expected.Treatment for AML may include chemotherapy, radiation therapy, stem cell transplant and/or immunotherapy. Your integrated team of leukemia experts will answer your questions and recommend treatment options based on your unique diagnosis and needs.
Therapeutic aspects: leukemia experts use state-of-the-art diagnostic tools, including advanced imaging and laboratory tests, to evaluate leukemia. This diagnostic evaluation takes about three to five days. In AML, the bone marrow may also make abnormal red blood cells and platelets. The number of these abnormal cells increases rapidly, and the abnormal (leukemia) cells begin to crowd out the normal white blood cells, red blood cells and platelets that the body needs.